Position in RPRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,496,421
+$3,120,306 QoQ
Shares Held
80,193
+179.5% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#216
of 644 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantbot Technologies LP holds $29,238,726 across 117 Biotechnology names. RPRX ranks #1 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
80,193 | $4,496,421 | |
| 2 | TECH |
BIO-TECHNE Corp
|
52,802 | $3,730,461 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
5,724 | $1,071,990 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
17,880 | $975,175 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,460 | $910,368 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,831 | $882,834 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
6,302 | $836,464 | |
| 8 | SYRE |
Spyre Therapeutics, Inc.
|
8,884 | $788,721 |
All Filings in RPRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,496,421 | 80,193 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,376,115 | 28,687 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,020,723 | 104,056 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,821,024 | 79,961 | Shares | Sole | 2025-11-12 | |
| 2023-06-30 | $787,743 | 25,626 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $215,279 | 5,975 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $31,813 | 805 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $39,738 | 989 | Shares | Sole | 2022-11-07 | |
| 2021-12-31 | $382,599 | 9,601 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||